Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer
Open Access
- 14 January 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 114 (3), 269-280
- https://doi.org/10.1038/bjc.2015.478
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular CarcinomaPLOS ONE, 2013
- The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancerCell Death & Disease, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Role of Pancreatic Stellate Cells in Pancreatic Cancer MetastasisThe American Journal of Pathology, 2010
- Isolation of Quiescent Human Pancreatic Stellate Cells: A Promising in vitro Tool for Studies of Human Pancreatic Stellate Cell BiologyPancreatology, 2010
- Interaction of Stellate Cells with Pancreatic Carcinoma CellsCancers, 2010
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)Journal of Clinical Oncology, 2010
- Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling PathwayCancer Research, 2009
- Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer CellsCancer Research, 2008
- Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor ProgressionCancer Research, 2008